Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Elevated titers of anti-thyroperoxidase antibodies in patients with multiple system atrophy: a pilot study.

Shihman B, Giladi N, Bleiberg M, Rosenberg A, Korczyn AD, Gurevich T.

Clin Neurol Neurosurg. 2013 Nov;115(11):2348-50. doi: 10.1016/j.clineuro.2013.08.013. Epub 2013 Sep 21.

PMID:
24063975
2.

Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study.

Wenning GK, Granata R, Krismer F, Dürr S, Seppi K, Poewe W, Bleasdale-Barr K, Mathias CJ.

Cerebellum. 2012 Mar;11(1):223-6. doi: 10.1007/s12311-011-0299-5.

PMID:
21822547
3.

Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease.

Pinkhardt EH, Kassubek J, Süssmuth S, Ludolph AC, Becker W, Jürgens R.

J Neurol. 2009 Sep;256(9):1438-46. doi: 10.1007/s00415-009-5131-5. Epub 2009 Apr 12.

PMID:
19363627
4.

Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.

Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D, Messina D, Testa C, Arabia G, Gambardella A, Lodi R, Quattrone A.

Radiology. 2013 Jun;267(3):843-50. doi: 10.1148/radiol.12120364. Epub 2013 Jan 17.

PMID:
23329659
5.

Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.

Sachin S, Shukla G, Goyal V, Singh S, Aggarwal V; Gureshkumar, Behari M.

Neurol India. 2008 Apr-Jun;56(2):122-6.

6.

Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy.

Lee JY, Lee WW, Kim JS, Kim HJ, Kim JK, Jeon BS.

Mov Disord. 2009 Jul 15;24(9):1290-5. doi: 10.1002/mds.22559.

PMID:
19412932
7.

Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.

Vogt IR, Lees AJ, Evert BO, Klockgether T, Bonin M, Wüllner U.

Exp Neurol. 2006 Jun;199(2):465-78. Epub 2006 Apr 19.

PMID:
16626704
9.

Red flags for multiple system atrophy.

Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK; European MSA Study Group.

Mov Disord. 2008 Jun 15;23(8):1093-9. doi: 10.1002/mds.21992.

PMID:
18442131
10.

Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.

Yamashita F, Hirayama M, Nakamura T, Takamori M, Hori N, Uchida K, Hama T, Sobue G.

Clin Auton Res. 2010 Jun;20(3):191-7. doi: 10.1007/s10286-009-0051-0. Epub 2010 Feb 3.

PMID:
20127386
11.

99mTc-TRODAT-1 imaging of multiple system atrophy.

Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC.

J Nucl Med. 2004 Jan;45(1):49-55.

12.

Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.

Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):605-8.

13.

Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.

Blain CR, Barker GJ, Jarosz JM, Coyle NA, Landau S, Brown RG, Chaudhuri KR, Simmons A, Jones DK, Williams SC, Leigh PN.

Neurology. 2006 Dec 26;67(12):2199-205.

PMID:
17190944
14.

FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.

Zhao T, Severijnen LA, van der Weiden M, Zheng PP, Oostra BA, Hukema RK, Willemsen R, Kros JM, Bonifati V.

J Neuropathol Exp Neurol. 2013 Jun;72(6):482-8. doi: 10.1097/NEN.0b013e318293c586.

15.

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM.

Neurobiol Dis. 2012 Jan;45(1):188-95. doi: 10.1016/j.nbd.2011.08.003. Epub 2011 Aug 10.

16.

Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.

Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T, Ogawa T.

Neuroradiology. 2012 Sep;54(9):947-55. doi: 10.1007/s00234-012-1009-9. Epub 2012 Jan 25.

PMID:
22274571
17.

Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.

Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, Kuriyama S.

J Neurol Sci. 2002 Jul 15;199(1-2):31-7.

PMID:
12084439
18.

Comparison of magnetic resonance imaging in subtypes of multiple system atrophy.

Lee EA, Cho HI, Kim SS, Lee WY.

Parkinsonism Relat Disord. 2004 Aug;10(6):363-8.

PMID:
15261878
19.
20.

Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.

Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.

Clin Endocrinol (Oxf). 2005 Apr;62(4):428-33.

PMID:
15807873
Items per page

Supplemental Content

Write to the Help Desk